LGND Competitors

NSD

Ligand Pharmaceuticals Incorporated

Healthcare•Biotechnology

Peers:AMGN•SPPI•GSK•MRK•PFE

$294.99

-$8.54 (-2.81%)

1Y Target

$344.25

+16.7%

Prev Close

$303.53

Open

$299.55

Volume

245.28K

Market Cap

$5.88B

52 Week Range

$175.89

$326.63

See all ETFs with LGND

Prev Close:$303.53

Open:$299.55

Volume:245.28K

Market Cap:$5.88B

52 Week Range

$175.89

$326.63

See all ETFs with LGND

69

MarketXLS Rank ®

75

Value ®

63

Technical

71

Quality

How is this score calculated?

LGND Competitors

Ligand Pharmaceuticals Incorporated

$294.99

-$8.54(-2.81%)

69

Overall

75

Value

63

Tech

71

Quality

How is this score calculated?

Market Cap

$5.88B

Volume

245.28K

52W Range

$175.89 - $326.63

Target Price

$344.25

LGND competitors: AMGN, SPPI, GSK, MRK, PFE. Ligand Pharmaceuticals Incorporated is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.

LGND Competitors Compared

Company	Price	Market cap	EPS est. (current yr)	Dividend yield	MarketXLS Rank
AMGN Amgen Inc.	$426.11	$230.37B	$22.94	2.33%	65
GSK GSK plc	$47.87	$94.64B	$4.78	3.79%	33
MRK Merck & Co., Inc.	$147.37	$350.29B	$2.66	2.31%	67
PFE Pfizer Inc.	$29.21	$166.49B	$2.96	5.89%	70

Get Ligand Pharmaceuticals Incorporated Data in Excel

Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.

BUY NOW

	A	B	C	D
1	Symbol	Price	Change	Volume
2	LGND	$294.99	-2.81%	245.28K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	LGND	$294.99	-2.8%	245.28K
3
4
5
6

Get Ligand Pharmaceuticals Incorporated Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW